Edition:
India

People: Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

85.80USD
18 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$85.80
Open
$85.47
Day's High
$86.91
Day's Low
$83.54
Volume
69,889
Avg. Vol
92,584
52-wk High
$127.74
52-wk Low
$64.25

Gardiner, Nathaniel 

Mr. Nathaniel S. Gardiner, J.D., is Senior Vice President and General Counsel of the Company. He has served as our Senior Vice President and General Counsel since May 2014 and has served as our Secretary since 1995. Previously Mr. Gardiner was a corporate and securities law partner for 25 years, most recently at Edwards Wildman Palmer LLP since October 2011, previously at Edwards Angell Palmer & Dodge LLP since November 2005, and before that at Palmer & Dodge LLP, where he represented Enanta and several other biotechnology companies. Mr. Gardiner received his A.B. from Harvard College and his J.D. from the University of Virginia School of Law.

Basic Compensation

Total Annual Compensation, USD 398,850
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 977,261
Fiscal Year Total, USD 1,376,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 4,300 171,828.00
Name Fiscal Year Total

Bruce Carter

394,190

Jay Luly

4,508,740

Paul Mellett

1,421,280

Yat Sun Or

1,524,000

Nathaniel Gardiner

1,376,110

Nathalie Adda

1,514,080
As Of  30 Sep 2018